About Michael Angeloni

This author has not yet filled in any details.
So far Michael Angeloni has created 903 blog entries.

Texas

The Health and Human Services Commissions’ Vendor Drug Program (VDP) announced that beginning Friday, May 18 prescribing pharmacists will be able to enroll in Texas Medicaid as an ordering, referring or prescribing provider. In accordance with federal regulation 42 CFR 455.410, prescribing pharmacists who write prescriptions for people enrolled in Medicaid fee-for-service must enroll as an ordering, referring or prescribing provider. This requirement does not apply to Medicaid managed care. To allow prescribing pharmacists time to enroll with Texas Medicaid Healthcare Partnership (TMHP), VDP will not deny pharmacy claims when the prescribing pharmacist is not enrolled until Monday, August 20. Please refer to the TMHP website for more information and enrollment instructions.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2018-05-25T10:46:12-04:00May 10, 2018|Texas|

Wisconsin

The Pharmacy Society of Wisconsin (PSW) is assisting the state Department of Justice with creating a list of local permanent drug disposal sites. If your pharmacy has a permanent drug disposal box, PSW asks that you email PSW’s Director of Public Affairs, Danielle Womack, with your pharmacy name and address.

For more information, contact NACDS’ Joel Kurzman at 847-905-0555.

2018-05-25T10:45:01-04:00May 10, 2018|Wisconsin|

Colorado

Letters submitted by NACDS and others opposing HB18-1538, legislation that would require pharmacies to post for the public each pharmacy’s drug prices, was killed in the House Health, Insurance and Environment Committee last week by a surprising 12-1 vote.

Also in Colorado…HB 18-1284, The Patient Drug Cost Savings Act, passed both the House of Representatives and the Senate and was signed into law by Gov. John Hickenlooper (D). Among its various provisions, the newly enacted law states a carrier or PBM acting on behalf of the carrier shall not prohibit a pharmacy or pharmacist from providing a covered person with information about the amount of the covered person’s cost share for the covered person’s prescription drug and the clinical efficacy of a more affordable alternative drug among its various provisions.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2018-05-10T15:53:29-04:00May 3, 2018|Colorado|

Illinois

The Department of Human Services announced that, for a second consecutive year, they will receive grant money from the 21st Century Cures Act to fight the opioid crisis. Among its uses, the $16 million grant will enable enhancements to the prescription monitoring program.

For more information, contact NACDS’ Joel Kurzman at 847-905-0555.

2018-05-10T15:51:49-04:00May 3, 2018|Illinois|

Missouri

The Board of Pharmacy is hosting a free webinar on Thursday, May 10 at 12:00 pm Central, featuring an update from Michael Boeger, Administrator of the Bureau of Narcotics and Dangerous Drugs, and Tom Glenski, R.Ph., Chief Inspector. Additional details and information to register are available online.

For more information, contact NACDS’ Joel Kurzman at 847-905-0555.

2018-05-10T15:48:43-04:00May 3, 2018|Missouri|

Nebraska

Creighton University will host the 15th annual Immunize Nebraska program on Friday, May 25. The registration deadline is Tuesday, May 22. Organizers include the the Creighton University Health Sciences Continuing Education, Immunization Task Force Metro Omaha, Methodist Health System and the state’s Department of Health and Human Services.

For more information, contact NACDS’ Joel Kurzman at 847-905-0555.

2018-05-10T15:47:08-04:00May 3, 2018|Nebraska|

Oklahoma

HB 2931, legislation mandating e-prescribing for Schedules II-V controlled substances by January 1, 2020, passed both the House of Representatives and the Senate and is headed to Gov. Mary Fallin (R) for consideration.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2018-05-10T15:45:56-04:00May 3, 2018|Oklahoma|

Oregon

Under the law allowing pharmacies to dispense naloxone in the state, there is a requirement that the information about the naloxone prescription must be reported to the state’s prescription drug monitoring program, just as pharmacies do with all controlled substances prescriptions. Concern has been expressed to the Board of Pharmacy by the Health Care Authority that pharmacies are not in compliance with this reporting requirement. Subsequently, the Board sent a reminder to pharmacies.

Also in Oregon…The first meeting of the Rules Advisory Committee to discuss proposed rules that would require all supervisors of Oregon pharmacists-in-charge (PICs) to be Oregon-licensed pharmacists and would give PICs carte blanch over the pharmacy operations without regard to company policy will be held Thursday, May 24 at the Board of Pharmacy’s office in Portland. The public is welcome to attend.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2018-05-10T15:44:41-04:00May 3, 2018|Oregon|
Go to Top